Cas:57946-67-5 N-(5-Amino-2-chlorophenyl)acetamide manufacturer & supplier

We serve Chemical Name:N-(5-Amino-2-chlorophenyl)acetamide CAS:57946-67-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-(5-Amino-2-chlorophenyl)acetamide

Chemical Name:N-(5-Amino-2-chlorophenyl)acetamide
CAS.NO:57946-67-5
Synonyms:N-(5-Amino-2-chlorophenyl)acetamide
Molecular Formula:C8H9ClN2O
Molecular Weight:184.62300
HS Code:2924299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:55.12000
Exact Mass:184.04000
LogP:2.53480

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N-(5-Amino-2-chlorophenyl)acetamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(5-Amino-2-chlorophenyl)acetamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(5-Amino-2-chlorophenyl)acetamide Use and application,N-(5-Amino-2-chlorophenyl)acetamide technical grade,usp/ep/jp grade.


Related News: Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. N-(5-Amino-2-chlorophenyl)acetamide manufacturer Remogliflozin is economical than other similar agents currently available in sodium glucose co-transporter-2 (SGLT2) inhibitors class, which shall help for its better access among middle and low socio-economic strata of the society, he added. N-(5-Amino-2-chlorophenyl)acetamide supplier Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business. N-(5-Amino-2-chlorophenyl)acetamide vendor China has granted conditional approval to its first self-developed treatment for Alzheimer��s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug. N-(5-Amino-2-chlorophenyl)acetamide factory Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors.